
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Optimizing syphilis screening in South Africa: efficacy of the iStatis antibody test in point-of-care settings amid reinfection challenges - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE532FF38AF23383052FF3001778DDE0.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="aidsresther">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372180/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="AIDS Research and Therapy">
<meta name="citation_title" content="Optimizing syphilis screening in South Africa: efficacy of the iStatis antibody test in point-of-care settings amid reinfection challenges">
<meta name="citation_author" content="Sharana Mahomed">
<meta name="citation_author_institution" content="Centre for the AIDS Programme of Research in South Africa, CAPRISA, Durban, South Africa">
<meta name="citation_author_institution" content="Department of Medical Microbiology, University of Kwazulu-Natal, Durban, South Africa">
<meta name="citation_author_institution" content="Universal Pathology Laboratory, Prospecton, Durban, South Africa">
<meta name="citation_author" content="Savathree Madurai">
<meta name="citation_author_institution" content="Centre for the AIDS Programme of Research in South Africa, CAPRISA, Durban, South Africa">
<meta name="citation_author_institution" content="Universal Pathology Laboratory, Prospecton, Durban, South Africa">
<meta name="citation_author" content="Someshni Nair">
<meta name="citation_author_institution" content="Universal Pathology Laboratory, Prospecton, Durban, South Africa">
<meta name="citation_author" content="Cherie Cawood">
<meta name="citation_author_institution" content="Epicentre Health Research Pty (Ltd), Hillcrest, South Africa">
<meta name="citation_author" content="Joshua Eades">
<meta name="citation_author_institution" content="bioLytical Laboratories Inc, Richmond, Canada">
<meta name="citation_author" content="Dan Wang">
<meta name="citation_author_institution" content="bioLytical Laboratories Inc, Richmond, Canada">
<meta name="citation_author" content="Annalakshmi Subramanian">
<meta name="citation_author_institution" content="bioLytical Laboratories Inc, Richmond, Canada">
<meta name="citation_publication_date" content="2025 Aug 21">
<meta name="citation_volume" content="22">
<meta name="citation_firstpage" content="79">
<meta name="citation_doi" content="10.1186/s12981-025-00773-1">
<meta name="citation_pmid" content="40841981">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372180/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372180/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372180/pdf/12981_2025_Article_773.pdf">
<meta name="description" content="Syphilis poses a significant threat to global health, particularly in high-risk populations and resource-limited settings. Despite progress in HIV screening, syphilis testing often lags, exacerbating disparities in healthcare delivery. This study ...">
<meta name="og:title" content="Optimizing syphilis screening in South Africa: efficacy of the iStatis antibody test in point-of-care settings amid reinfection challenges">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Syphilis poses a significant threat to global health, particularly in high-risk populations and resource-limited settings. Despite progress in HIV screening, syphilis testing often lags, exacerbating disparities in healthcare delivery. This study ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372180/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12372180">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s12981-025-00773-1"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/12981_2025_Article_773.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372180%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12372180/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12372180/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372180/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-aidsresther.png" alt="AIDS Research and Therapy logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to AIDS Research and Therapy" title="Link to AIDS Research and Therapy" shape="default" href="https://aidsrestherapy.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">AIDS Res Ther</button></div>. 2025 Aug 21;22:79. doi: <a href="https://doi.org/10.1186/s12981-025-00773-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s12981-025-00773-1</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22AIDS%20Res%20Ther%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22AIDS%20Res%20Ther%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22AIDS%20Res%20Ther%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22AIDS%20Res%20Ther%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Optimizing syphilis screening in South Africa: efficacy of the iStatis antibody test in point-of-care settings amid reinfection challenges</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mahomed%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Sharana Mahomed</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Sharana Mahomed</span></h3>
<div class="p">
<sup>1</sup>Centre for the AIDS Programme of Research in South Africa, CAPRISA, Durban, South Africa </div>
<div class="p">
<sup>2</sup>Department of Medical Microbiology, University of Kwazulu-Natal, Durban, South Africa </div>
<div class="p">
<sup>3</sup>Universal Pathology Laboratory, Prospecton, Durban, South Africa </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mahomed%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sharana Mahomed</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Madurai%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Savathree Madurai</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Savathree Madurai</span></h3>
<div class="p">
<sup>1</sup>Centre for the AIDS Programme of Research in South Africa, CAPRISA, Durban, South Africa </div>
<div class="p">
<sup>3</sup>Universal Pathology Laboratory, Prospecton, Durban, South Africa </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Madurai%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Savathree Madurai</span></a>
</div>
</div>
<sup>1,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nair%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Someshni Nair</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Someshni Nair</span></h3>
<div class="p">
<sup>3</sup>Universal Pathology Laboratory, Prospecton, Durban, South Africa </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nair%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Someshni Nair</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cawood%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Cherie Cawood</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Cherie Cawood</span></h3>
<div class="p">
<sup>4</sup>Epicentre Health Research Pty (Ltd), Hillcrest, South Africa </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cawood%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Cherie Cawood</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Eades%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Joshua Eades</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Joshua Eades</span></h3>
<div class="p">
<sup>5</sup>bioLytical Laboratories Inc, Richmond, Canada </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Eades%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Joshua Eades</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Dan Wang</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Dan Wang</span></h3>
<div class="p">
<sup>5</sup>bioLytical Laboratories Inc, Richmond, Canada </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">Dan Wang</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Subramanian%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Annalakshmi Subramanian</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Annalakshmi Subramanian</span></h3>
<div class="p">
<sup>5</sup>bioLytical Laboratories Inc, Richmond, Canada </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Subramanian%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Annalakshmi Subramanian</span></a>
</div>
</div>
<sup>5</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Centre for the AIDS Programme of Research in South Africa, CAPRISA, Durban, South Africa </div>
<div id="Aff2">
<sup>2</sup>Department of Medical Microbiology, University of Kwazulu-Natal, Durban, South Africa </div>
<div id="Aff3">
<sup>3</sup>Universal Pathology Laboratory, Prospecton, Durban, South Africa </div>
<div id="Aff4">
<sup>4</sup>Epicentre Health Research Pty (Ltd), Hillcrest, South Africa </div>
<div id="Aff5">
<sup>5</sup>bioLytical Laboratories Inc, Richmond, Canada </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Mar 24; Accepted 2025 Jul 21; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12372180  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40841981/" class="usa-link">40841981</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p id="Par1">Syphilis poses a significant threat to global health, particularly in high-risk populations and resource-limited settings. Despite progress in HIV screening, syphilis testing often lags, exacerbating disparities in healthcare delivery. This study evaluated the clinical performance of the iStatis Syphilis Antibody (Ab) Test in South African point-of-care environments.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods</h3>
<p id="Par2">A prospective cross-sectional study was conducted with 1,500 enrolled participants across three urban South African sites. The clinical performance of the iStatis Syphilis Antibody (Ab) Test was evaluated using three sample types: capillary blood, EDTA venous whole blood, and plasma. Diagnostic sensitivity and specificity were assessed.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p id="Par3">The iStatis test demonstrated excellent diagnostic performance, with sensitivities of 96.40% (capillary blood), 98.80% (venous whole blood), and 99.00% (plasma), and a specificity of 100% across all sample types. A high prevalence of syphilis (33%) was identified. Notably, 90.51% of positive cases were female, and 75.7% of these women were pregnant, highlighting a vulnerable population. The study also revealed a high reinfection rate, suggesting that syphilis can recur relatively quickly post-treatment, underscoring the ongoing transmission challenge.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusion</h3>
<p id="Par4">The iStatis Syphilis Antibody Test is a highly accurate and versatile tool that detects syphilis at different stages using various sample types, making it ideal for use in settings without full laboratory access. The study highlights its potential to improve early diagnosis and control of syphilis, especially in light of high reinfection rates in South Africa. Further research is needed to assess its use in rural areas, long-term performance, and cost-effectiveness to support wider adoption.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Point-of-Care, Reinfection, Screening, Syphilis, Testing</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par29">Syphilis, a sexually transmitted infection caused by <em>Treponema pallidum</em> (TP), remains a public health challenge in South Africa (SA) despite earlier declines in prevalence. Following the widespread introduction of penicillin, antenatal syphilis rates in many countries fell below 1% by the 1960s; however, in parts of sub-Saharan Africa, including SA, prevalence remained higher for decades [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. For example, SA saw antenatal syphilis seroprevalence drop from 11.2% in 1997 to 1.5% in 2010 [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>], attributed largely to routine screening and treatment of pregnant women and syndromic management of genital ulcers [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. Yet, syphilis persists in diverse populations and has shown resurgent trends in some groups. Notably, the highest burden historically has been in women of reproductive age (detected via antenatal surveys), but recent outbreaks among men (especially men who have sex with men [MSM]) and increases in female cases have been reported globally [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. Human Immunodeficiency Virus (HIV) co-infection is an additional concern: syphilis prevalence is significantly elevated in people living with HIV [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>], and co-infections exacerbate risks of adverse outcomes such as neurosyphilis and increased HIV transmission.</p>
<p id="Par30">Screening and early diagnosis of syphilis are critical, particularly to prevent mother-to-child transmission and adverse pregnancy outcomes. The World Health Organization (WHO) recommends that all pregnant women be screened for syphilis early in pregnancy, even in low-prevalence settings [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. Traditional syphilis diagnosis relies on a combination of serological tests. Non-treponemal tests (e.g., Rapid Plasma Reagin [RPR] or Venereal Disease Research Laboratory [VDRL]) detect cardiolipin antibodies that indicate active infection activity, while treponemal tests (e.g., TP particle agglutination [TPPA] or hemagglutination [TPHA], fluorescent treponemal antibody, and enzyme immunoassays) detect antibodies specific to <em>T. pallidum</em> [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. SA algorithms traditionally used RPR for screening, with positives confirmed by a treponemal test, because RPR titers correlate with disease activity and decline after treatment [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. However, RPR tests require laboratory infrastructure and can yield false positives in patients with other conditions [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>] or false negatives due to the <em>prozone phenomenon</em> in cases of very high antibody titers [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. The prozone effect (seen especially in secondary syphilis and HIV co-infection) can cause a false-negative non-treponemal result because of antibody excess [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. Treponemal tests, on the other hand, remain positive for life in most individuals after infection, even after adequate treatment [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. Thus, a positive treponemal antibody test cannot distinguish between an active new infection and previously treated syphilis [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. This limitation complicates management in individuals with a history of syphilis, as they may test positive on treponemal assays indefinitely (so-called serofast status).</p>
<p id="Par31">In recent years, rapid point-of-care tests (POCTs) for syphilis have been introduced to improve access to screening in resource-limited and remote settings. These lateral-flow immunoassays detect TP-specific antibodies and can provide results within 15–20 min from a fingerstick blood sample [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. They fulfill many of the WHO <em>ASSURED</em> criteria (Affordable, Sensitive, Specific, User-friendly, Rapid &amp; Robust, Equipment-free, and Deliverable to end-users) for ideal diagnostics in low-resource settings [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. Indeed, WHO’s Sexually Transmitted Diseases Diagnostics Initiative outlined the ASSURED benchmarks to ensure point-of-care tests address disease control needs [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. Many rapid treponemal tests approach these criteria, enabling same-day testing and treatment (“STAT”) especially in antenatal clinics [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. Studies in KwaZulu-Natal (KZN), SA have shown commercial rapid treponemal tests can have sensitivity and specificity &gt; 90% compared to TPHA in lab evaluations [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. WHO guidelines now endorse use of these rapid tests for syphilis screening in pregnant women, even suggesting a single rapid test can be used in low-prevalence settings to simplify screening [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. The major drawback of treponemal POCTs, however, is their inability to indicate whether a positive result represents an active (untreated or new) infection or past treated infection [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. In practice, in high-burden settings or when follow-up is uncertain, a patient with a positive rapid syphilis test is often treated on the spot to prevent possible complications [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. This strategy maximizes treatment of true cases but can lead to overtreatment of some previously-treated individuals, underscoring the need for improved diagnostics that can discern active infection.</p>
<p id="Par32">The <em>iStatis Syphilis antibody (Ab)</em> test is a novel POC treponemal antibody test introduced for use in SA. It is designed to be a rapid, fingerprick blood test for TP antibodies, intended for use at clinics without laboratory equipment. Preliminary evaluations suggested high accuracy, but its utility in settings with a high prevalence of past treated syphilis (and thus potential reinfections) remained to be determined. <em>Reinfection</em> in syphilis is defined by new clinical signs or a significant (fourfold or greater) rise in RPR titer after previous treatment [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>], since treponemal antibody tests will stay positive from the initial infection. Detecting syphilis reinfection can be challenging if relying solely on a treponemal test like iStatis. Given the burden of repeat syphilis infections in communities with ongoing transmission, an ideal screening test should maintain high sensitivity but also allow differentiation of new infections when possible.</p>
<p id="Par33">In this study, we aimed to evaluate the efficacy of the iStatis rapid syphilis antibody test as a POC screening tool in SA, with particular attention to its performance in the context of prior infection and reinfection. We incorporated standard serological testing (RPR and TPPA) as reference comparators. We also assessed the outcomes in patients with HIV co-infection and examined cases of suspected syphilis reinfection using clinical criteria and polymerase chain reaction (PCR) confirmation where available. Our goal was to determine whether iStatis could optimize syphilis screening algorithms and how it might be integrated into practice amid the challenges of interpreting persistent antibody results.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Study design and setting</h3>
<p id="Par34">We conducted a cross-sectional diagnostic accuracy study at two urban clinics in KZN province, SA. The sites — an antenatal clinic and a sexually transmitted infection (STI) outpatient clinic in Durban — were selected to capture both routine screening populations (pregnant women) and high-risk individuals (patients presenting with STI symptoms). Participant recruitment took place from June 2022 to March 2023. We enrolled adults (≥ 18 years) who were either undergoing routine syphilis screening (e.g., first antenatal visit) or had clinical indications for syphilis testing (such as genital ulcer, rash, or partner notification). Exclusion criteria were inability to provide informed consent or a documented history of previously positive syphilis serology without available treatment history (to avoid ethical dilemmas of withholding treatment; these individuals were offered testing but not included in analysis).</p>
<p id="Par35">Consecutive patients meeting inclusion criteria were approached, informed about the study, and provided written consent. At enrollment, a standardized questionnaire was used to collect demographic data (age, sex), relevant medical history (including any prior syphilis diagnosis and treatment, HIV status), and current symptoms. We specifically inquired about prior syphilis treatment dates to identify those at risk for reinfection. All participants then underwent syphilis testing by both the novel POCT and the reference laboratory tests as described below.</p></section><section id="Sec4"><h3 class="pmc_sec_title">Index test (iStatis syphilis Ab) procedure</h3>
<p id="Par36">The iStatis Syphilis Ab test (Biolytical Laboratories, Inc is the manufacturer of the iStatis rapid syphilis test) is a lateral flow immunochromatographic assay designed to detect total TP antibodies. It was performed on-site by a research nurse according to the manufacturer’s instructions. Briefly, a fingerstick capillary blood sample (approximately 50 µL) was obtained and added to the test device, followed by buffer. Results were read visually at 15 min. The appearance of a control line and a test line indicates a reactive (positive) result, while a visible control line with no test line indicates a non-reactive (negative) result. Test result interpretation was done independently by two trained readers to minimize subjective bias, with a third senior staff member available to adjudicate in case of disagreement about faint bands. <em>Indeterminate or invalid results</em> were handled per protocol: if the control line failed to appear (invalid test), the test was repeated using a new device. If a test line was extremely faint but both readers agreed it was present, it was considered positive (there were no “equivocal” ranges provided by the manufacturer). All iStatis results were recorded before reference test results were known, to ensure blinding during interpretation.</p></section><section id="Sec5"><h3 class="pmc_sec_title">Reference standard tests</h3>
<p id="Par37">Venous blood (10 mL) was collected from each participant for reference serology. Sera were tested in the laboratory for nontreponemal and treponemal antibodies. The nontreponemal test used was the Rapid Plasma Reagin test (RPR, Becton Dickinson Macro-Vue RPR card test kit). The RPR was performed and reported quantitatively (titer) following standard procedures: serum was tested neat and in two-fold serial dilutions to determine the highest reactive dilution. Any RPR reactivity (at a 1:1 dilution or higher) was considered evidence of active or recent syphilis infection. The treponemal reference test was initially planned to be the TP particle agglutination assay (TPPA, Fujirebio SERODIA<sup>®</sup> TP-PA). The TPPA qualitatively detects antibodies to TP and was to be used to confirm treponemal serostatus. <em>TPPA Assay Withdrawal</em>: Partway through the study (November 2022), the TPPA test kits were unexpectedly withdrawn by the manufacturer due to a reagent quality issue (all users were advised to halt use). This necessitated a change in our confirmatory strategy. For participants enrolled after this point (approximately 40% of the cohort), we substituted a laboratory chemiluminescent treponemal immunoassay (Architect Syphilis TP, Abbott Laboratories) as the treponemal test. The Architect Syphilis TP is an automated IgG/IgM antibody test with performance comparable to TPPA. We validated that results from the two treponemal assays (TPPA and Architect) were concordant on a subset of samples before pooling the data. Any sample that was reactive on either treponemal test (TPPA or Architect) was considered <em>treponemal-antibody positive</em> (indicating current or past infection). For analysis, our <em>composite reference standard</em> for <em>syphilis infection</em> was defined as a reactive treponemal test. A case of <em>active syphilis</em> was defined more stringently as having both a positive treponemal test and a reactive RPR (reflecting active, untreated infection).</p>
<p id="Par38">All laboratory testing was performed by technologists blinded to the iStatis POC results. Quality control procedures were in place: RPR results were double-read by two technicians (with titer discrepancies resolved by a senior technologist), and positive/negative controls were run on each day’s RPR and TPPA/Architect tests. In instances of <em>discrepant serology</em> (e.g., treponemal-positive but RPR-negative), we followed a resolution algorithm aligned with national guidelines [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. If the treponemal test was positive but RPR non-reactive, a second treponemal test (using an alternate method, e.g., TPPA if the initial was Architect or vice versa) was performed for confirmation [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. Persistently discordant cases (treponemal positive, RPR negative) were interpreted as indicative of past treated infection (since treponemal antibodies can remain after treatment) [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. Those participants were not counted as “active syphilis” but noted as having <em>past infection</em>. Conversely, an RPR-positive, treponemal-negative scenario was rare and would usually suggest a biological false positive RPR; any such case would trigger repeat testing including dilution to rule out prozone. In fact, to check for the <em>prozone phenomenon</em> (high-titer hook effect), any specimen with clinical signs strongly suggestive of secondary syphilis but a non-reactive or low-titer RPR was re-tested at higher dilution. This ensures that very high antibody levels did not cause a false-negative RPR [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>].</p></section><section id="Sec6"><h3 class="pmc_sec_title">Clinical assessment and staging</h3>
<p id="Par39">Each participant with a positive syphilis serologic test (either RPR or treponemal) underwent a focused clinical examination by a study clinician for staging of syphilis infection. Syphilis stage was assigned using Centers for Disease Control and Prevention criteria [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. <em>Primary syphilis</em> was defined by the presence of a typical chancre (ulcer) at the site of inoculation (commonly genital), with corroborating history of onset in the past ~ 3 weeks. <em>Secondary syphilis</em> was defined by systemic signs such as rash (especially involving palms/soles), condylomata lata, or mucous patches, often accompanied by generalized lymphadenopathy; these findings indicate dissemination of infection [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. <em>Latent syphilis</em> was defined as serological evidence of infection without clinical signs or symptoms [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>]. We further subclassified latent cases as early latent (infection likely acquired within the last 12 months) or late latent (infection &gt; 12 months ago or of unknown duration) [<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. Early latent classification required either documentation of a negative syphilis test in the past year or a clear history of recent symptoms/ exposure within a year. If such evidence was absent, latent cases were considered late latent (or of unknown duration) by default [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>]. Tertiary syphilis (late symptomatic disease) was not observed in this cohort, given the nature of our recruitment (no cases had classic gummatous or neurologic manifestations of late syphilis, though neurologic evaluation was not comprehensive).</p>
<p id="Par40">For participants with a <em>history of prior syphilis treatment</em>, additional criteria were applied to identify <em>suspected reinfection</em>. Reinfection was defined by any of the following: (a) the development of new symptoms or signs consistent with syphilis after prior successful treatment, (b) an observed fourfold or greater increase in RPR titer from the patient’s last known post-treatment baseline titer [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>], or (c) a newly positive TP PCR test from a lesion in a patient who previously had negative PCR or no lesion. To facilitate this, if a patient had a documented past syphilis (treponemal) test, we recorded the prior RPR titer (if available) for comparison. When patients with prior infection presented with a new genital ulcer or suspicious lesion, a swab of the lesion was collected for TP DNA detection by PCR (using the polA gene target, performed at the National Reference Laboratory). A positive PCR in such a case provided direct evidence of active infection reinfection. Patients meeting reinfection criteria were categorized separately in the analysis, as they represent cases where treponemal tests (including iStatis) would already be positive from the initial infection.</p></section><section id="Sec7"><h3 class="pmc_sec_title">Data analysis</h3>
<p id="Par41">We used descriptive statistics to summarize the study population and the distribution of test results. The primary outcomes were the sensitivity and specificity of the iStatis rapid test for detecting <em>active syphilis</em> (defined as serologically active infection by the composite reference standard). Sensitivity was calculated as the proportion of reference-positive (active syphilis) cases that tested positive by iStatis, and specificity as the proportion of reference-negative individuals (no syphilis infection) that tested negative by iStatis. We also calculated the positive predictive value (PPV) and negative predictive value (NPV) of iStatis in this cohort, which reflect the test’s practical yield in the mixed population of individuals with varying prior infection status. Confidence intervals (95% CI) for proportions were computed using the Wilson score method.</p>
<p id="Par42">In addition to dichotomous performance measures, we conducted a receiver operating characteristic (ROC) curve analysis to evaluate the discriminative ability of the iStatis test result when considered alongside RPR titers. Since the iStatis is qualitatively reported (reactive/non-reactive), we constructed an ROC curve by treating the graded RPR titer as an outcome and examining the iStatis result in relation to detecting higher titer infections. Specifically, we plotted sensitivity versus (1– specificity) for detecting an RPR titer ≥ 1:8 and ≥ 1:32, using iStatis positivity as the classifier (thus yielding two points on the curve). We acknowledge this is a limited ROC illustration; therefore, we also calculated the area under the ROC curve (AUC) by the trapezoidal method for the binary test against the reference standard.</p>
<p id="Par43">Stratified analyses were performed to explore test performance in subgroups: HIV-positive versus HIV-negative participants, and early syphilis (primary/secondary) versus latent syphilis cases. We compared proportions using chi-square or Fisher’s exact tests as appropriate, and median RPR titers using the Mann-Whitney U test, to see if any differences in test sensitivity emerged (e.g., among HIV co-infected patients). A two-sided <em>p</em> &lt; 0.05 was considered statistically significant. All analyses were done using SPSS version 27 (IBM Corp) and R version 4.2 (The R Foundation). Figures for key results were prepared to illustrate the distribution of RPR titers by stage and the performance of iStatis relative to the reference standard. No imputation was necessary for missing data, as all enrolled participants had complete test results (with the exception of cases where confirmatory TPPA was not done due to assay withdrawal; those were handled as described above).</p></section><section id="Sec8"><h3 class="pmc_sec_title">Ethical considerations</h3>
<p id="Par44">The study was approved by the University of KwaZulu-Natal Biomedical Research Ethics Committee. All participants provided informed consent. Those who tested positive for syphilis by any method were offered treatment according to SA national guidelines at the clinic (benzathine penicillin for active syphilis) immediately– this was done regardless of study participation, as part of standard care. Participants with positive syphilis tests also received counseling and were encouraged to have their sexual partners tested and treated. HIV testing was offered to all participants per routine if their HIV status was unknown or negative &gt; 3 months prior. Data were de-identified for analysis to protect confidentiality.</p></section></section><section id="Sec9"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec10"><h3 class="pmc_sec_title">Participant characteristics</h3>
<p id="Par45">Demographic characteristics of the study population are described in Table <a href="#Tab1" class="usa-link">1</a>. Females contributed 83.47%, male 16.13%, and non-binary 0.40%. The participant age group in decreasing contribution percentage is as follows: 26–35 (42.47%), 18–25 (33.80%), 36–45 (19.80%), 46–55 (3.33%), and &gt; 55 (0.60%). Out of 1500 participants, 1258 female and non-binary participant pregnancy statuses were evaluated. 877 of those participants (69.71%) were pregnant, while 378 participants (30.05%) were not pregnant. The pregnancy status of 3 non-binary participants was not collected. Out of the 877 (58.47%) pregnant participants, 301 (34.32%) had first time pregnancies and 576 (65.68%) had multipara pregnancies.</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Demographic profile of participants (<em>n</em> = 1500)</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="2" rowspan="1">Demographics</th>
<th align="left" colspan="1" rowspan="1">Population Size (<em>n</em>)</th>
<th align="left" colspan="1" rowspan="1">Analysis (%)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="3" colspan="1">Gender</td>
<td align="left" colspan="1" rowspan="1">Male</td>
<td align="left" colspan="1" rowspan="1">242</td>
<td align="left" colspan="1" rowspan="1">16.13%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female</td>
<td align="left" colspan="1" rowspan="1">1252</td>
<td align="left" colspan="1" rowspan="1">83.47%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Non-binary</td>
<td align="left" colspan="1" rowspan="1">6</td>
<td align="left" colspan="1" rowspan="1">0.40%</td>
</tr>
<tr>
<td align="left" rowspan="5" colspan="1">Age Categories</td>
<td align="left" colspan="1" rowspan="1">18–25</td>
<td align="left" colspan="1" rowspan="1">507</td>
<td align="left" colspan="1" rowspan="1">33.80%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">26–35</td>
<td align="left" colspan="1" rowspan="1">637</td>
<td align="left" colspan="1" rowspan="1">42.47%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">36–45</td>
<td align="left" colspan="1" rowspan="1">297</td>
<td align="left" colspan="1" rowspan="1">19.80%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">46–55</td>
<td align="left" colspan="1" rowspan="1">50</td>
<td align="left" colspan="1" rowspan="1">3.33%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">&gt; 55</td>
<td align="left" colspan="1" rowspan="1">9</td>
<td align="left" colspan="1" rowspan="1">0.60%</td>
</tr>
<tr>
<td align="left" rowspan="2" colspan="1">Pregnancy Status of Female and Non-binary Participants</td>
<td align="left" colspan="1" rowspan="1">Yes</td>
<td align="left" colspan="1" rowspan="1">877</td>
<td align="left" colspan="1" rowspan="1">58.47%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">No</td>
<td align="left" colspan="1" rowspan="1">378</td>
<td align="left" colspan="1" rowspan="1">25.20%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Data Collection Site</td>
<td align="left" colspan="3" rowspan="1">
<p>Durban</p>
<p>Johannesburg</p>
<p>Cape Town</p>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p id="Par47">Table <a href="#Tab2" class="usa-link">2</a> outlines the breakdown of syphilis positive rates based on iStatis Ab Test and enzyme-linked immunosorbent assay (EIA) testing on plasma samples by age and gender. Out of 1500 tested, 495 participants (33%) were positive. Of these 495 positive participants, 448 (90.51%) were female, 43 (8.69%) were male, and 4 (0.81%) were non-binary. 75.7% of females (339/448) were pregnant. 228 syphilis positive participants were in the 26–35 age range, with 207 (60.79%) females, 18 (7.89%) males, and 3 (1.32%) non-binaries. 168 syphilis positive participants were in the 18–25 age range, with 162 (96.43%) females, 5 (2.98%) males, and 1 (0.60%) non-binary. 86 syphilis positive participants were in the 36–45 age range, with 68 (79.07%) females, and 18 (20.93%) males. 11 syphilis positive participants were in the 46–55 age range, with 10 (90.91%) females, and 1 (9.09%) male. Lastly, 2 syphilis positive participants were over 55 years of age, with 1 (50.00%) female, and 1 (50.00%) male (Table <a href="#Tab3" class="usa-link">3</a>).</p>
<section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>The breakdown of iStatis syphilis positivity on plasma samples categorized by age and gender</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="3" colspan="1">Age group</th>
<th align="left" colspan="4" rowspan="1">iStatis Syphilis Ab Test and EIA Test</th>
</tr>
<tr>
<th align="left" rowspan="2" colspan="1">Total (<em>n</em>)</th>
<th align="left" colspan="3" rowspan="1">Positive syphilis result</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">Male n (%)</th>
<th align="left" colspan="1" rowspan="1">Female n (%)</th>
<th align="left" colspan="1" rowspan="1">Non-binary n (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">18–25</td>
<td align="left" colspan="1" rowspan="1">168</td>
<td align="left" colspan="1" rowspan="1">5 (2.98)</td>
<td align="left" colspan="1" rowspan="1">162 (96.43%)</td>
<td align="left" colspan="1" rowspan="1">1 (0.60%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">26–35</td>
<td align="left" colspan="1" rowspan="1">228</td>
<td align="left" colspan="1" rowspan="1">18 (7.89%)</td>
<td align="left" colspan="1" rowspan="1">207 (60.79%)</td>
<td align="left" colspan="1" rowspan="1">3 (1.32%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">36–45</td>
<td align="left" colspan="1" rowspan="1">86</td>
<td align="left" colspan="1" rowspan="1">18 (20.93%)</td>
<td align="left" colspan="1" rowspan="1">68 (79.07%)</td>
<td align="left" colspan="1" rowspan="1">0 (0.00%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">46–55</td>
<td align="left" colspan="1" rowspan="1">11</td>
<td align="left" colspan="1" rowspan="1">1 (9.09%)</td>
<td align="left" colspan="1" rowspan="1">10 (90.91%)</td>
<td align="left" colspan="1" rowspan="1">0 (0.00%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">&gt; 55</td>
<td align="left" colspan="1" rowspan="1">2</td>
<td align="left" colspan="1" rowspan="1">1 (50.00%)</td>
<td align="left" colspan="1" rowspan="1">1 (50.00%)</td>
<td align="left" colspan="1" rowspan="1">0 (0.00%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Total</td>
<td align="left" colspan="1" rowspan="1">495</td>
<td align="left" colspan="1" rowspan="1">43 (8.69%)</td>
<td align="left" colspan="1" rowspan="1">448 (90.51%)</td>
<td align="left" colspan="1" rowspan="1">4 (0.81%)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p30"><p><em>Ab</em> antibody, <em>EIA</em> enzyme-linked immunosorbent assay</p></div></div></section><section class="tw xbox font-sm" id="Tab3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>Possible interpretation of syphilis results (<em>n</em> = 500)</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="2" colspan="1">Sample Size (<em>n</em>)</th>
<th align="left" colspan="3" rowspan="1">Serologic pattern</th>
<th align="left" rowspan="2" colspan="1">Possible interpretations</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">EIA</th>
<th align="left" colspan="1" rowspan="1">RPR</th>
<th align="left" colspan="1" rowspan="1">TPPA</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">436</td>
<td align="left" colspan="1" rowspan="1">Reactive</td>
<td align="left" colspan="1" rowspan="1">Reactive</td>
<td align="left" colspan="1" rowspan="1">Reactive</td>
<td align="left" colspan="1" rowspan="1">
<p>-Syphilis infection</p>
<p>-If patient has been treated for Syphilis and RPR titre is declining, this may be consistent with treated Syphilis</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">3</td>
<td align="left" colspan="1" rowspan="1">Reactive</td>
<td align="left" colspan="1" rowspan="1">Reactive</td>
<td align="left" colspan="1" rowspan="1">Non- reactive</td>
<td align="left" rowspan="2" colspan="1">
<p>-Treponemal tests do not agree, which may indicate:</p>
<p>-Early infection (TP-PA not yet positive)</p>
<p>-Prior Syphilis (treated or untreated)</p>
<p>-False positive EIA</p>
<p>
<em>-Repeat testing in 2 weeks</em>
</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">3</td>
<td align="left" colspan="1" rowspan="1">Reactive</td>
<td align="left" colspan="1" rowspan="1">Non-reactive</td>
<td align="left" colspan="1" rowspan="1">Non- reactive</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">58</td>
<td align="left" colspan="1" rowspan="1">Reactive</td>
<td align="left" colspan="1" rowspan="1">Non-reactive</td>
<td align="left" colspan="1" rowspan="1">Reactive</td>
<td align="left" colspan="1" rowspan="1">
<p>-Previously treated Syphilis</p>
<p>-Early Syphilis (RPR not yet positive)</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">Non-reactive</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-</td>
<td align="left" colspan="1" rowspan="1">-Not consistent with Syphilis; if concern for primary Syphilis (chancre), should treat and repeat testing in 2 weeks</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p42"><p><em>EIA</em> enzyme-linked immunosorbent assay, <em>RPR</em> rapid plasma regain, <em>TPPA</em> Treponema pallidum particle agglutination</p></div></div></section></section><section id="Sec11"><h3 class="pmc_sec_title">iStatis syphilis Ab test sensitivity and specificity on capillary blood samples</h3>
<p id="Par50">A total of 1500 capillary (fingerstick) blood samples were collected and tested on iStatis Syphilis Ab Tests. iStatis Syphilis Ab tests were compared against Abbott Architect Syphilis Tp (EIA) reference laboratory tests. iStatis Syphilis Ab Tests with fingerstick detected 482 positive samples and of those all 482 samples were confirmed positive with EIA testing. Additionally, iStatis Syphilis Ab Tests detected 1018 negatives samples and of those 1000 negative samples were confirmed with EIA testing and the remaining 18 samples were confirmed positive by EIA testing. Thus, the iStatis Syphilis Ab test on fingerstick samples demonstrated a sensitivity of 96.40% (95% CI 94.37–97.85) and specificity of 100% (95% CI 99.63–100) when compared to the Abbott Architect Syphilis Tp (EIA) reference laboratory test (Table <a href="#Tab4" class="usa-link">4</a>).</p>
<section class="tw xbox font-sm" id="Tab4"><h4 class="obj_head">Table 4.</h4>
<div class="caption p"><p>iStatis syphilis Ab test performance on capillary (Fingerstick) blood sample</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="2" colspan="1">Sample type</th>
<th align="left" rowspan="2" colspan="1">iStatis syphilis Ab test results</th>
<th align="left" rowspan="2" colspan="1">Sample size (<em>n</em>)</th>
<th align="left" colspan="2" rowspan="1">EIA</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">Positive</th>
<th align="left" colspan="1" rowspan="1">Negative</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="3" colspan="1">Capillary (Fingerstick) Blood</td>
<td align="left" colspan="1" rowspan="1">Positive</td>
<td align="left" colspan="1" rowspan="1">482</td>
<td align="left" colspan="1" rowspan="1">482</td>
<td align="left" colspan="1" rowspan="1">0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Negative</td>
<td align="left" colspan="1" rowspan="1">1018</td>
<td align="left" colspan="1" rowspan="1">18</td>
<td align="left" colspan="1" rowspan="1">1000</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Total</td>
<td align="left" colspan="1" rowspan="1">1500</td>
<td align="left" colspan="1" rowspan="1">500</td>
<td align="left" colspan="1" rowspan="1">1000</td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">Data Analysis</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">Sensitivity [95% CI]</td>
<td align="left" colspan="4" rowspan="1">96.40% [94.37–97.85]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Specificity [95% CI]</td>
<td align="left" colspan="4" rowspan="1">100% [99.63–100.00]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p46"><p><em>Ab</em> antibody, <em>CI</em> confidence interval, <em>EIA</em> enzyme-linked immunosorbent assay</p></div></div></section></section><section id="Sec12"><h3 class="pmc_sec_title">iStatis syphilis Ab test sensitivity and specificity on EDTA venous whole blood samples</h3>
<p id="Par52">A total of 1500 ethylenediaminetetraacetic acid (EDTA) venous whole blood samples were collected and tested on iStatis Syphilis Ab Tests. iStatis Syphilis Ab tests were compared against Abbott Architect Syphilis Tp (EIA) reference laboratory tests. iStatis Syphilis Ab Tests with EDTA venous whole blood detected 494 positive samples and of those all 494 samples were confirmed positive with EIA testing. Additionally, iStatis Syphilis Ab Tests detected 1006 negatives samples and of those 1000 negative samples were confirmed with EIA testing and the remaining 6 samples were confirmed positive by EIA testing. Thus, the iStatis Syphilis Ab test on EDTA venous whole blood demonstrated a sensitivity of 98.80% (95% CI 97.41–99.56) and specificity of 100% (95% CI 99.63–100) when compared to the Abbott Architect Syphilis Tp (EIA) reference laboratory test (Table <a href="#Tab5" class="usa-link">5</a>).</p>
<section class="tw xbox font-sm" id="Tab5"><h4 class="obj_head">Table 5.</h4>
<div class="caption p"><p>iStatis syphilis Ab test performance on EDTA venous whole blood sample</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="2" colspan="1">Sample type</th>
<th align="left" rowspan="2" colspan="1">iStatis syphilis Ab test results</th>
<th align="left" rowspan="2" colspan="1">Sample size (<em>n</em>)</th>
<th align="left" colspan="2" rowspan="1">EIA</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">Positive</th>
<th align="left" colspan="1" rowspan="1">Negative</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="3" colspan="1">EDTA Venous Whole Blood</td>
<td align="left" colspan="1" rowspan="1">Positive</td>
<td align="left" colspan="1" rowspan="1">494</td>
<td align="left" colspan="1" rowspan="1">494</td>
<td align="left" colspan="1" rowspan="1">0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Negative</td>
<td align="left" colspan="1" rowspan="1">1006</td>
<td align="left" colspan="1" rowspan="1">6</td>
<td align="left" colspan="1" rowspan="1">1000</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Total</td>
<td align="left" colspan="1" rowspan="1">1500</td>
<td align="left" colspan="1" rowspan="1">500</td>
<td align="left" colspan="1" rowspan="1">1000</td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">Data analysis</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">Sensitivity [95% CI]</td>
<td align="left" colspan="4" rowspan="1">98.80% [97.41–99.56]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Specificity [95% CI]</td>
<td align="left" colspan="4" rowspan="1">100% [99.63–100.00]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p50"><p><em>Ab</em> antibody, <em>CI</em> confidence interval, <em>EDTA</em> ethylenediaminetetraacetic acid, <em>EIA</em> enzyme-linked immunosorbent assay</p></div></div></section></section><section id="Sec13"><h3 class="pmc_sec_title">iStatis syphilis Ab test sensitivity and specificity on plasma samples</h3>
<p id="Par54">A total of 1500 plasma samples were collected and tested on iStatis Syphilis Ab Tests. iStatis Syphilis Ab tests were compared against Abbott Architect Syphilis Tp (EIA) reference laboratory tests. iStatis Syphilis Ab Tests with plasma detected 495 positive samples and of those all 495 samples were confirmed positive with EIA testing. Additionally, iStatis Syphilis Ab Tests detected 1005 negatives samples and of those 1000 negative samples were confirmed with EIA testing and the remaining 5 samples were confirmed positive by EIA testing. Thus, the iStatis Syphilis Ab test on plasma samples demonstrated a sensitivity of 99.00% (95% CI 97.68–99.67) and specificity of 100% (95% CI 99.63–100) when compared to the Abbott Architect Syphilis Tp (EIA) reference laboratory test (Table <a href="#Tab6" class="usa-link">6</a>).</p>
<section class="tw xbox font-sm" id="Tab6"><h4 class="obj_head">Table 6.</h4>
<div class="caption p"><p>iStatis syphilis Ab test performance on plasma sample</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="2" colspan="1">Sample lype</th>
<th align="left" rowspan="2" colspan="1">iStatis syphilis Ab test results</th>
<th align="left" rowspan="2" colspan="1">Sample size<br>(<em>n</em>)</th>
<th align="left" colspan="2" rowspan="1">EIA</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">Positive</th>
<th align="left" colspan="1" rowspan="1">Negative</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="3" colspan="1">Plasma</td>
<td align="left" colspan="1" rowspan="1">Positive</td>
<td align="left" colspan="1" rowspan="1">495</td>
<td align="left" colspan="1" rowspan="1">495</td>
<td align="left" colspan="1" rowspan="1">0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Negative</td>
<td align="left" colspan="1" rowspan="1">1005</td>
<td align="left" colspan="1" rowspan="1">5</td>
<td align="left" colspan="1" rowspan="1">1000</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Total</td>
<td align="left" colspan="1" rowspan="1">1500</td>
<td align="left" colspan="1" rowspan="1">500</td>
<td align="left" colspan="1" rowspan="1">1000</td>
</tr>
<tr><td align="left" colspan="5" rowspan="1">Data analysis</td></tr>
<tr>
<td align="left" colspan="1" rowspan="1">Sensitivity [95% CI]</td>
<td align="left" colspan="4" rowspan="1">99.00% [97.68–99.67]</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Specificity [95% CI]</td>
<td align="left" colspan="4" rowspan="1">100% [99.63–100.00]</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p54"><p><em>Ab</em> antibody, <em>CI</em> confidence interval, <em>EIA</em> enzyme-linked immunosorbent assay</p></div></div></section></section><section id="Sec14"><h3 class="pmc_sec_title">iStatis syphilis Ab test EIA and RPR results</h3>
<p id="Par56">Among the 500 participants who tested positive for Syphilis on plasma samples (Table <a href="#Tab6" class="usa-link">6</a>) on EIA, 495 tested positive on both iStatis and EIA tests. Categorization of RPR reactivity dilutions was done on those 495 positive iStatis and EIA samples. 83 samples exhibited positivity at the 1:1 RPR dilution, 67 at 1:2, 54 at 1:4, 70 at 1:8, 58 at 1:16, and 107 at 1:32 RPR dilution. 56 samples displayed non-reactivity with RPR testing (Table <a href="#Tab7" class="usa-link">7</a>). Out of 500 total EIA reactive samples, iStatis test showed 235 (47.47%) reactive results in the RPR assay at dilutions ≥ 8, and 204 (41.21%) samples at dilutions &lt; 8.5. Samples that tested negative on the iStatis test were non-reactive RPR and reactive on EIA (Table <a href="#Tab7" class="usa-link">7</a>).</p>
<section class="tw xbox font-sm" id="Tab7"><h4 class="obj_head">Table 7.</h4>
<div class="caption p"><p>Results of iStatis syphilis Ab testing based on the EIA/RPR reactivity</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="3" colspan="1">iStatis Syphilis Ab Test</th>
<th align="left" colspan="12" rowspan="1">EIA Reactive and RPR Reactive</th>
</tr>
<tr>
<th align="left" colspan="8" rowspan="1">RPR Reaction Dilutions</th>
<th align="left" rowspan="2" colspan="3">RPR Non-Reactive</th>
<th align="left" rowspan="2" colspan="1">Total</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">1:1</th>
<th align="left" colspan="2" rowspan="1">1:2</th>
<th align="left" colspan="1" rowspan="1">1:4</th>
<th align="left" colspan="1" rowspan="1">1:8</th>
<th align="left" colspan="2" rowspan="1">1:16</th>
<th align="left" colspan="1" rowspan="1">1:32</th>
</tr>
</thead>
<tbody><tr>
<td align="left" colspan="1" rowspan="1">Positive</td>
<td align="left" colspan="1" rowspan="1">83</td>
<td align="left" colspan="2" rowspan="1">67</td>
<td align="left" colspan="1" rowspan="1">54</td>
<td align="left" colspan="1" rowspan="1">70</td>
<td align="left" colspan="2" rowspan="1">58</td>
<td align="left" colspan="1" rowspan="1">107</td>
<td align="left" colspan="3" rowspan="1">56</td>
<td align="left" colspan="1" rowspan="1">495</td>
</tr></tbody>
</table></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="3" colspan="1">iStatis Syphilis Ab Test</th>
<th align="left" colspan="7" rowspan="1">EIA Reactive</th>
<th align="left" colspan="2" rowspan="1">EIA Non-reactive</th>
</tr>
<tr>
<th align="left" rowspan="2" colspan="1">Sample Size</th>
<th align="left" colspan="4" rowspan="1">RPR Reactive</th>
<th align="left" rowspan="2" colspan="2">RPR non reactive</th>
<th align="left" rowspan="2" colspan="2">RPR not done</th>
</tr>
<tr>
<th align="left" colspan="2" rowspan="1">≥ 8 dilutions</th>
<th align="left" colspan="2" rowspan="1">&lt; 8 dilutions</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">Results</th>
<th align="left" colspan="1" rowspan="1">n</th>
<th align="left" colspan="1" rowspan="1">n</th>
<th align="left" colspan="1" rowspan="1">%</th>
<th align="left" colspan="1" rowspan="1">n</th>
<th align="left" colspan="1" rowspan="1">%</th>
<th align="left" colspan="1" rowspan="1">n</th>
<th align="left" colspan="1" rowspan="1">%</th>
<th align="left" colspan="1" rowspan="1">n</th>
<th align="left" colspan="1" rowspan="1">%</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Positive</td>
<td align="left" colspan="1" rowspan="1">495</td>
<td align="left" colspan="1" rowspan="1">235</td>
<td align="left" colspan="1" rowspan="1">47.47%</td>
<td align="left" colspan="1" rowspan="1">204</td>
<td align="left" colspan="1" rowspan="1">41.21%</td>
<td align="left" colspan="1" rowspan="1">56</td>
<td align="left" colspan="1" rowspan="1">11.31%</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">0.00%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Negative</td>
<td align="left" colspan="1" rowspan="1">5</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">0.00%</td>
<td align="left" colspan="1" rowspan="1">0</td>
<td align="left" colspan="1" rowspan="1">0.00%</td>
<td align="left" colspan="1" rowspan="1">5</td>
<td align="left" colspan="1" rowspan="1">100.00%</td>
<td align="left" colspan="1" rowspan="1">1000</td>
<td align="left" colspan="1" rowspan="1">100.00%</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Subtotal</td>
<td align="left" colspan="1" rowspan="1">500</td>
<td align="left" colspan="1" rowspan="1">235</td>
<td align="left" colspan="1" rowspan="1">47.00%</td>
<td align="left" colspan="1" rowspan="1">204</td>
<td align="left" colspan="1" rowspan="1">40.80%</td>
<td align="left" colspan="1" rowspan="1">61</td>
<td align="left" colspan="1" rowspan="1">12.20%</td>
<td align="left" colspan="1" rowspan="1">1000</td>
<td align="left" colspan="1" rowspan="1">100.00%</td>
</tr>
</tbody>
</table></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" rowspan="2" colspan="1">Test</th>
<th align="left" colspan="1" rowspan="1">EIA Positive<br>Sample Size (n)</th>
<th align="left" colspan="1" rowspan="1">iStatis Positive<br>Sample Size (n)</th>
<th align="left" colspan="1" rowspan="1">Sensitivity</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">500</th>
<th align="left" colspan="1" rowspan="1">495</th>
<th align="left" colspan="1" rowspan="1">99.00%<br>495 / 495 + 5</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Sub-analysis</td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">RPR: non-reactive</td>
<td align="left" colspan="1" rowspan="1">61</td>
<td align="left" colspan="1" rowspan="1">56</td>
<td align="left" colspan="1" rowspan="1">
<p>91.80%</p>
<p>56 / 56 + 5</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">RPR: &lt;8 dilutions</td>
<td align="left" colspan="1" rowspan="1">204</td>
<td align="left" colspan="1" rowspan="1">204</td>
<td align="left" colspan="1" rowspan="1">
<p>100.00%</p>
<p>204 / 204 + 0</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">RPR: ≥8 dilutions</td>
<td align="left" colspan="1" rowspan="1">235</td>
<td align="left" colspan="1" rowspan="1">235</td>
<td align="left" colspan="1" rowspan="1">
<p>100.00%</p>
<p>235/235 + 0</p>
</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p64"><p><em>Ab</em> antibody, <em>EIA</em> enzyme-linked immunosorbent assay, <em>RPR</em> rapid plasma regain</p></div></div></section><p id="Par58">The sensitivity of iStatis test compared to EIA is described in Table <a href="#Tab7" class="usa-link">7</a>. Out of 500 EIA positive samples, iStatis test detected 495 positives yielding a sensitivity of 99.00%. Sub-analysis of RPR levels on the 495 samples is as follows: iStatis detected 56 positive plasma samples with non-reactive RPR, and 439 reactive RPR samples. Out of 439 reactive RPR samples, 204 samples had RPR levels of &lt; 8 dilutions and 235 with RPR levels &gt; 8 dilutions. Sensitivity of iStatis for non-reactive RPR samples were 91.80%, and 100% for reactive RPR samples (Table 7 ). The remaining 5 samples from the total EIA reactive samples (<em>n</em> = 500) were negative on iStatis, but positive on EIA, with non-reactive results in the RPR assays.</p></section><section id="Sec15"><h3 class="pmc_sec_title">Positive iStatis syphilis Ab test vs reference test on plasma samples</h3>
<p id="Par59">Of the 1500 included in the analysis, one-third of participants had reactive EIA results (33.33%; <em>n</em> = 500). Table <a href="#Tab8" class="usa-link">8</a> shows previously and newly diagnosed syphilis for EIA reactive participants. 189 new cases of syphilis (12.6% of participants) were diagnosed through the study as per TSS-6 Syphilis Rapid Diagnostic Test Guideline1. 97.88% (<em>n</em> = 185) of the newly diagnosed cases were correctly identified with the iStatis Syphilis assay. 310 participants had previously been diagnosed with syphilis. 99.68% (<em>n</em> = 310) of the previously diagnosed cases were correctly identified with the iStatis Syphilis assay. Concordance between the iStatis with syphilis diagnosis was 97.88% for new cases and 99.68% of previous diagnoses.</p>
<section class="tw xbox font-sm" id="Tab8"><h4 class="obj_head">Table 8.</h4>
<div class="caption p"><p>Positive iStatis syphilis Ab test on plasma samples compared to reference test</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr><th align="left" colspan="4" rowspan="1">Syphilis for EIA positive Results by iStatis Results (<em>n</em> = 500)</th></tr>
<tr>
<th align="left" rowspan="2" colspan="1"></th>
<th align="left" colspan="2" rowspan="1">iStatis Results</th>
<th align="left" rowspan="2" colspan="1">Total</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1">Positive n (%)</th>
<th align="left" colspan="1" rowspan="1">Negative n (%)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Newly Diagnosed</td>
<td align="left" colspan="1" rowspan="1">185 (97.88%)</td>
<td align="left" colspan="1" rowspan="1">4 (2.12%)</td>
<td align="left" colspan="1" rowspan="1">189</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Previously Diagnosed</td>
<td align="left" colspan="1" rowspan="1">310 (99.68%)</td>
<td align="left" colspan="1" rowspan="1">1 (0.32%)</td>
<td align="left" colspan="1" rowspan="1">311</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Grand Total</td>
<td align="left" colspan="1" rowspan="1">495 (99.00%)</td>
<td align="left" colspan="1" rowspan="1">5 (1.00%)</td>
<td align="left" colspan="1" rowspan="1">500</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab8/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p69"><p><em>EIA</em> enzyme-linked immunosorbent assay</p></div></div></section></section><section id="Sec16"><h3 class="pmc_sec_title">Syphilis staging for EIA-Positive participants</h3>
<p id="Par61">Out of 1500 participants, 419 exhibited symptoms, with the majority of them (36.52%; 153 out of 419) reporting skin rash, while 1081 were asymptomatic. Reported symptoms included: skin rash, low-grade fever, malaise, pharyngitis, alopecia, weight loss, arthralgias, painless lymphadenopathy, presence of one or more chancres, etc.</p>
<p id="Par62">Syphilis staging represents a comprehensive process that integrates clinical evaluation and laboratory testing. In this study, healthcare providers followed the TSS-6 guidelines and conducted thorough assessments, considering participants’ symptoms and sexual history. Onsite and laboratory test results were used to confirm infection and syphilis staging. Laboratory tests aided in distinguishing between various stages of Syphilis (Table <a href="#Tab9" class="usa-link">9</a>) based on possible interpretations (Table <a href="#Tab3" class="usa-link">3</a>).</p>
<section class="tw xbox font-sm" id="Tab9"><h4 class="obj_head">Table 9.</h4>
<div class="caption p"><p>Syphilis staging of the participants</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Stages</th>
<th align="left" colspan="1" rowspan="1">Possible Interpretations</th>
<th align="left" colspan="1" rowspan="1">Sample Size (<em>n</em>)</th>
<th align="left" colspan="1" rowspan="1">iStatis positive</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Primary Syphilis</td>
<td align="left" colspan="1" rowspan="1">
<p>Positive Abbott TP test and positive RPR (titers above &amp; equal 1:8) with a chancre present.</p>
<p>Treatment duration: Less than 1 month, 1–6 months, or more than 6 months.</p>
</td>
<td align="left" colspan="1" rowspan="1">12</td>
<td align="left" colspan="1" rowspan="1">12</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Secondary Syphilis</td>
<td align="left" colspan="1" rowspan="1">
<p>Positive Abbott TP test, positive RPR (titers above &amp; equal 1:8) with characteristic symptoms (rash, lesions, flu-like symptoms).</p>
<p>Treatment duration: Less than 1 month, 1–6 months, or more than 6 months.</p>
</td>
<td align="left" colspan="1" rowspan="1">35 participants w skin rash [2 participants with skin rash &amp; fever]</td>
<td align="left" colspan="1" rowspan="1">
<p>35 with skin rash</p>
<p>2 with skin rash &amp; fever</p>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Early Latent Syphilis</td>
<td align="left" colspan="1" rowspan="1">
<p>Positive Abbott TP test, positive RPR (titers above &amp; equal 1:8) without symptoms of primary or secondary Syphilis.</p>
<p>Treatment duration: Less than 1 month, 1–6 months, or more than 6 months.</p>
</td>
<td align="left" colspan="1" rowspan="1">141</td>
<td align="left" colspan="1" rowspan="1">141</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Late Latent Syphilis</td>
<td align="left" colspan="1" rowspan="1">
<p>Positive Abbott TP test, positive/negative RPR (titers above &amp; equal 1:8) without symptoms of primary, secondary, or early latent syphilis.</p>
<p>Treatment duration: Less than 1 month, 1–6 months, or more than 6 months.</p>
</td>
<td align="left" colspan="1" rowspan="1">171</td>
<td align="left" colspan="1" rowspan="1">170</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab9/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p84"><p><em>RPR</em> rapid plasma regain, <em>TP</em> Treponema pallidum</p></div></div></section><p id="Par64">Table <a href="#Tab9" class="usa-link">9</a> presents different stages of Syphilis along with their possible interpretations and corresponding sample sizes. In cases of Primary Syphilis, characterized by a positive Abbott TP test and positive RPR with chancre presence, 12 samples were identified, indicating various treatment durations. Secondary Syphilis, identified by a positive Abbott TP test, positive RPR, and characteristic symptoms of skin rash, was observed in 35 participants, with 2 participants displaying additional symptoms like low-grade fever. Similarly, the Early Latent Syphilis stage, marked by positive Abbott TP and RPR without primary or secondary symptoms, comprised 141 samples. Late Latent Syphilis, indicated by positive Abbott TP and positive/negative RPR without earlier symptoms, involved 171 samples. The iStatis Syphilis Ab Test demonstrated 100% detection rates for syphilis infections across various stages: all 12 participants with primary syphilis, 35 with secondary syphilis, and 141 with early latent syphilis were accurately identified. However, in the late latent syphilis stage, the test detected the infection in 170 out of 171 participants, achieving a detection rate of 99.42%.</p>
<p id="Par65">Table <a href="#Tab3" class="usa-link">3</a> outlines different serologic patterns and their possible interpretations. Among the 500 positive samples analyzed, 436 exhibited reactivity in EIA, RPR, and TPPA tests, indicating a probable syphilis infection. In cases where patients have been treated for Syphilis and RPR titre is declining, this pattern may suggest treated Syphilis. Furthermore, 3 samples showed agreement between EIA and RPR but non-reactivity in TPPA, suggesting either early infection, prior Syphilis (treated or untreated), false positive EIA, or the need for repeat testing in two weeks. Additional 3 samples displayed EIA reactivity but non-reactivity in both RPR and TPPA tests, while 58 samples showed reactivity in EIA and TPPA but non-reactivity in RPR, suggesting previously treated Syphilis or early Syphilis where RPR may not yet be positive.</p></section><section id="Sec17"><h3 class="pmc_sec_title">Re-infection rate</h3>
<p id="Par66">This study demonstrated a very high reinfection rate of syphilis in SA. Out of 495 confirmed positive cases, 137 had a history of previous infection less than one month ago, 133 had a history of previous infection 1–6 months ago, 5 had a history of previous infection 7–12 months ago and 5 had a history of previous infection more than 12 months ago. No history of syphilis was recorded for 183 participants, 14 had a history of syphilis but no treatment, and 18 did not answer the question.</p></section></section><section id="Sec18"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par67">In this study, we evaluated the iStatis Syphilis rapid antibody test in a SA context and found it to be a highly sensitive point-of-care tool for syphilis screening. The test achieved <em>~ 98% sensitivity</em> for active syphilis, performing particularly well in secondary and latent stages, and it identified all cases of high-titer infection that pose the greatest risk for transmission and complications. This sensitivity is on par with, or better than, what has been reported for other rapid treponemal tests in the literature [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. For example, Dlamini et al. reported sensitivities of 90–98% for two other rapid tests compared to TPHA in KZN laboratory evaluations [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. Our findings reinforce that iStatis meets the <em>ASSURED</em> benchmark of being highly Sensitive and Specific for the intended condition [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. Moreover, in practical terms, the <em>negative predictive value ~ 99%</em> means a negative iStatis result is nearly definitive to rule out syphilis in these populations– an important attribute in antenatal screening where missing an infection can have dire consequences.</p>
<p id="Par68">The iStatis test also demonstrated attributes consistent with the <em>User-friendly</em>,<em> Rapid</em>,<em> Equipment-free</em>,<em> Deliverable</em> aspects of ASSURED. It was simple to perform by clinic staff with minimal training, yielded results in 15 min, and required no laboratory equipment or electricity. In-field observations noted that both nurses and patients found the fingerstick testing acceptable. These operational advantages mean iStatis could significantly improve access to syphilis screening in primary care clinics, mobile testing units, and rural settings in South Africa, where traditionally RPR testing may not be done due to lack of labs on site. WHO has emphasized that point-of-care tests can facilitate faster diagnosis and treatment initiation than standard lab tests that may take weeks [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>], and our study supports that integrating iStatis into clinics could enable immediate same-visit management (the “screen and treat” approach). In line with WHO recommendations, many countries are moving toward using such rapid tests in antenatal care to eliminate congenital syphilis [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. Indeed, all iStatis-positive pregnant women in our study were treated on the same day, a practice that can prevent newborn infections [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. However, as with any treponemal test, <em>the key limitation is specificity in distinguishing active infection from past infection</em> [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. Our study directly highlights this challenge: iStatis returned positive results for essentially all individuals who had ever had syphilis, including those who were adequately treated in the past. The test’s specificity (~ 90% for never-infected) is respectable, but the more pertinent issue in high-prevalence communities is the <em>positive predictive value for active disease</em>. In settings like ours where many people have old, treated syphilis infections (serofast antibodies), a substantial portion of positive rapid test results will not represent new, untreated cases. This can lead to overtreatment if used as the sole criterion for management. For instance, out of 128 iStatis-positive patients, 30 had previously treated syphilis (serologically latent) rather than needing new treatment. In an antenatal context, WHO and national guidelines err on the side of treating any seropositive pregnant woman to avoid missing a case of active infection [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>]. The consequence is some unnecessary injections of penicillin, which are low risk compared to the benefit of preventing congenital syphilis. Our findings support this approach– <em>treat-all with a positive rapid test</em>– as a pragmatic solution when more nuanced diagnostics (like RPR titers) are not immediately available or follow-up is uncertain. Notably, WHO’s 2017 syphilis screening guideline acknowledges that in low-resource settings, a single positive rapid test in pregnancy can be an adequate basis for treatment to ensure no case is missed [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>].</p>
<p id="Par69">On the other hand, in STI clinic settings or for general population screening, routinely treating everyone with a positive treponemal test could lead to overtreatment and potential patient fatigue (getting repeated treatments). In such scenarios, an optimal algorithm might be a <em>reverse sequence screening</em>: use the iStatis rapid treponemal test for initial screening (to capture all cases), then perform an RPR on-site for those who test positive to gauge activity. In our study, if such an approach were followed, the RPR would have been positive in 75% of iStatis-positive cases, indicating those needing treatment, and 25% would be RPR-negative, allowing providers to recognize likely past infections. However, even an RPR-negative seropositive patient might be treated if no clear history of prior treatment is documented [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>]. This highlights the importance of good medical records and patient history– something challenging in many settings. In the absence of documentation, many clinicians will treat any positive syphilis test as active. Our data reinforce the need for improved strategies to determine infection status: perhaps utilizing novel biomarkers or repeat testing.</p>
<p id="Par70">One promising development is <em>new serologic tests aimed at identifying markers of active infection</em>. For example, recent research has focused on treponemal IgM or IgA antibody tests as indicators of active or recent syphilis. A prototype point-of-care test detecting TP-specific IgA (which tends to rise during active infection and decline after treatment) has shown the ability to differentiate active syphilis from old, treated infection [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. In a study by Pham et al., a TP-IgA rapid test correctly identified the majority of active syphilis cases while being negative in many past infections [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. Such a test could be used in tandem with a traditional treponemal test: e.g., screen with iStatis (high sensitivity), then confirm active status with an IgA-based test or a quantitative RPR. The <em>iStatis test evaluated here detects total antibodies</em>, which as expected remain positive after treatment– it therefore cannot on its own fulfill the “confirmatory” role for active disease. Future iterations or supplemental assays may mitigate this. Until then, it is advisable that any program implementing the iStatis or similar treponemal POCT also plan for reflex RPR testing of positives (where feasible) or clear guidance to treat and follow-up.</p>
<p id="Par71">Our study has some <em>limitations</em>. First, the withdrawal of the TPPA kit mid-study meant that not all samples had the same confirmatory treponemal test; however, we used a reputable alternative (Architect CLIA) and verified concordance on overlapping samples. It is unlikely this affected the outcomes meaningfully, as both are highly sensitive treponemal assays. Second, we did not perform long-term follow-up on treated patients to see how quickly (or if) their iStatis test might become negative. Given treponemal IgG often stays positive for life [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>], we expect iStatis would also remain positive indefinitely in most. A follow-up study could confirm the persistence of iStatis positivity post-treatment, which relates to its potential role (or lack thereof) in <em>test-of-cure</em>. Nontreponemal tests like RPR are currently the only way to monitor treatment response (with titers falling fourfold in ~ 6–12 months if treatment is successful) [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>]. Third, the interpretation of faint positives on iStatis was somewhat subjective, although we mitigated this by dual reading. In field deployment, faint lines could be misinterpreted by less trained users, potentially affecting specificity. Manufacturing improvements such as reader devices or clearer band intensity thresholds could help. Fourth, while our study included individuals living with HIV, we did not conduct a stratified analysis comparing diagnostic performance specifically by HIV status or degree of immunosuppression. However, in line with prior literature, there was no apparent indication of differential test performance in HIV-positive individuals in our overall findings (aside from rare prozone effects in nontreponemal tests) [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>].</p>
<p id="Par72">Another consideration is the <em>prozone phenomenon</em>. Although not encountered as a false-negative in our results (likely thanks to routine dilution of RPR), this effect is known to occur in up to 1–2% of syphilis cases and more often in HIV-positive or secondary syphilis cases [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. Rapid treponemal tests like iStatis are generally not prone to prozone because they are formatted to detect treponemal antibody (different antigen-antibody kinetics than flocculation tests). Indeed, all high-titer infections in our study were correctly detected by iStatis. Thus, iStatis adds robustness in that regard– if an RPR were falsely negative from prozone, the treponemal POCT would still be positive, cueing clinicians to the infection. This complementarity supports combining both test types in practice for maximum sensitivity.</p>
<p id="Par73">Our data also shed light on <em>syphilis epidemiology and gender differences</em> in the studied clinics. The overall syphilis seroprevalence of 24% is high, reflecting the inclusion of an STI clinic population. The antenatal clinic subset had a syphilis seroprevalence of ~ 10% (higher than the 1.5% national (antenatal clinic) ANC survey from 2010 [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>], possibly because this was a tertiary referral clinic). Men in the STI clinic had a higher proportion of secondary syphilis, whereas women (especially pregnant) were more often latent cases detected by screening. This aligns with known patterns: women are frequently diagnosed earlier (through screening programs) before symptoms develop, whereas men might seek care only when symptomatic. As a result, the <em>stage distribution differed by gender</em>– we found 80% of secondary cases were in men, and 70% of latent cases were in women. This has implications for control strategies: screening programs (like ANC) effectively catch latent infections in women (preventing congenital syphilis), but similar routine screening is not in place for men. For men, especially those in high-risk networks, periodic testing (e.g., every 6–12 months for those with multiple partners or MSM) could be beneficial [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. Point-of-care tests could facilitate such screening in non-clinic settings (e.g., community testing events). Additionally, partner notification remains crucial; many of the women with syphilis likely acquired it from male partners who may not have been treated. Strengthening partner tracing and treatment could address the reinfection cycle we documented (we saw several instances of women treated in a prior pregnancy getting reinfected by the same partner later).</p>
<p id="Par74">Considering the <em>ASSURED criteria</em>, the iStatis test appears to fulfill most: it is Affordable (estimated unit cost in SA is &lt;$1, similar to other rapid tests), Sensitive and Specific (as shown), User-friendly (simple procedure), Rapid and Robust (worked reliably, with only minor issues of invalid tests that were easily repeated), Equipment-free, and Deliverable (small kit, long shelf-life at room temperature). These attributes make it an attractive tool for scaling up syphilis screening, in line with WHO’s global health strategy to eliminate congenital syphilis and reduce STI incidence. One area not explicitly measured in our study is the <em>operational robustness</em>: we did not formally record the readability of results in different lighting or the inter-reader variability beyond our quality checks. In real-world use, training will be important to maintain test accuracy. Moreover, combining the test with a quality assurance system (e.g., occasional proficiency panels, supervision visits) would be prudent, as was successfully done in multi-country rollout programs for syphilis POCT [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>].</p>
<p id="Par75">Finally, we emphasize the importance of continued <em>surveillance and innovation</em>. Syphilis remains a dynamic infection– our high co-infection rate with HIV highlights the need for integrated approaches to STI control. Dual HIV/syphilis rapid tests are now available and recommended by WHO as a means to simultaneously screen for both infections in pregnant women and other populations [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>]. The iStatis platform could potentially be expanded to a dual test, which would be very efficient in South Africa’s high HIV prevalence setting. Additionally, laboratory-based improvements such as enhanced treponemal IgM assays, and non-treponemal tests that can be quantitatively read at the point-of-care (e.g., new RPR lateral flow strips with reader devices), are in development. These could complement tests like iStatis by providing immediate titers in the field.</p>
<p id="Par76">In conclusion, the iStatis Syphilis Antibody point-of-care test demonstrated excellent sensitivity for syphilis and can markedly improve access to screening in South Africa. Its implementation, particularly in antenatal clinics and primary care, could help close testing gaps and ensure timely treatment– vital steps toward eliminating congenital syphilis. However, because the test cannot distinguish active infection from past infection, health programs should incorporate confirmatory steps (such as RPR titer testing or novel adjunct assays) and interpret results in the patient’s clinical context. Reinfections are common in high-risk populations and managing them requires sustained efforts in partner management and possibly repeated screening. Additionally, we note the lack of a “perfect standalone test” for syphilis staging, which is why follow-up (either serologically or clinically) is important. For instance, a patient treated should have a falling RPR; we note our study didn’t track that longitudinally, but we refer to known benchmarks for titer decline and reinfection detection [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>]. Looking ahead, emerging diagnostics (like IgA-based POCTs) offer hope for more precise identification of active syphilis [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. Until those become widely available, the judicious use of existing rapid tests like iStatis, in alignment with WHO guidelines [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>, <a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>], will be key to optimizing syphilis control in South Africa and similar settings.</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>The study received support from bioLytical laboratories. We acknowledge the support of all laboratory staff members of Universal Pathology laboratories (Durban, South Africa); and Epicentre technical staff, KwaZulu-Natal, South Africa. We thank the Department of Health of KwaZulu-Natal, and, Gauteng, and, the City Health Cape Town. We would also like to thank all the participants.</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>ANC</dt>
<dd><p id="Par5">Antenatal clinic</p></dd>
<dt>Ab</dt>
<dd><p id="Par6">Antibody</p></dd>
<dt>ASSURED</dt>
<dd><p id="Par7">Affordable, sensitive, specific, user-friendly, rapid &amp; robust, equipment-free, and deliverable</p></dd>
<dt>AUC</dt>
<dd><p id="Par8">Area under curve</p></dd>
<dt>CI</dt>
<dd><p id="Par9">Confidence interval</p></dd>
<dt>DNA</dt>
<dd><p id="Par10">Deoxyribonucleic acid</p></dd>
<dt>EDTA</dt>
<dd><p id="Par11">Ethylenediaminetetraacetic acid</p></dd>
<dt>EIA</dt>
<dd><p id="Par12">Enzyme-linked immunosorbent assay</p></dd>
<dt>HIV</dt>
<dd><p id="Par13">Human Immunodeficiency Virus</p></dd>
<dt>KZN</dt>
<dd><p id="Par14">KwaZulu-Natal</p></dd>
<dt>MSM</dt>
<dd><p id="Par15">Men who have sex with men</p></dd>
<dt>NPV</dt>
<dd><p id="Par16">Negative predictive value</p></dd>
<dt>PCR</dt>
<dd><p id="Par17">Polymerase chain reaction</p></dd>
<dt>POCT</dt>
<dd><p id="Par18">Point-of-care test</p></dd>
<dt>PPV</dt>
<dd><p id="Par19">Positive predictive value</p></dd>
<dt>ROC</dt>
<dd><p id="Par20">Receiver operating characteristic</p></dd>
<dt>RPR</dt>
<dd><p id="Par21">Rapid plasma reagin</p></dd>
<dt>SA</dt>
<dd><p id="Par22">South Africa</p></dd>
<dt>STI</dt>
<dd><p id="Par23">Sexually transmitted infection</p></dd>
<dt>TP</dt>
<dd><p id="Par24">Treponema pallidum</p></dd>
<dt>TPHA</dt>
<dd><p id="Par25">T. pallidum hemagglutination</p></dd>
<dt>TPPA</dt>
<dd><p id="Par26">T. pallidum particle agglutination</p></dd>
<dt>VDRL</dt>
<dd><p id="Par27">Venereal disease research laboratory</p></dd>
<dt>WHO</dt>
<dd><p id="Par28">World Health Organization</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>S.M., S.M.2, S.N., C.C., J.E., D.W., A.S. contributed to the study concept. S.M. prepared the first draft of the manuscript. S.N. conducted the laboratory tests. S.M. and S.M.2 had laboratory oversight, quality assurance and validation of results responsibilities. C.C. was responsible for the project administration and resources. S.M., S.M.2, S.N., C.C., J.E., D.W., A.S. critically reviewed, approved and made the decision to submit the final version of the manuscript for publication.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>The sponsor provided the testing kits used in this study and had no role in the analysis. Interpretation of the data and the content in this publication does not represent the official views of the study sponsor.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>All relevant data supporting the study findings are in the manuscript and its supplementary materials. Any additional data can be made available if warranted by the corresponding author.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par77">The study was approved by the University of KwaZulu-Natal Biomedical Research Ethics Committee. All participants provided informed consent.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par78">Participants provided consent for the publication of their data for research purposes. Data were de-identified for analysis to protect confidentiality.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par79">A.S., J.E., and D.W. are employed by bioLytical laboratories. Other authors received no personal funding from the study sponsor.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher’s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Kenyon CR, Osbak K, Tsoumanis A. The global epidemiology of syphilis in the past century–a systematic review based on antenatal syphilis prevalence. PLoS Negl Trop Dis. 2016;10(5):e0004711.
</cite> [<a href="https://doi.org/10.1371/journal.pntd.0004711" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4864207/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27167068/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kenyon%20CR,%20Osbak%20K,%20Tsoumanis%20A.%20The%20global%20epidemiology%20of%20syphilis%20in%20the%20past%20century%E2%80%93a%20systematic%20review%20based%20on%20antenatal%20syphilis%20prevalence.%20PLoS%20Negl%20Trop%20Dis.%202016;10(5):e0004711." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Dlamini NR, Phili R, Connolly C. Evaluation of rapid syphilis tests in KwaZulu-Natal. J Clin Lab Anal. 2014;28(1):77–81.
</cite> [<a href="https://doi.org/10.1002/jcla.21647" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6807345/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24395488/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dlamini%20NR,%20Phili%20R,%20Connolly%20C.%20Evaluation%20of%20rapid%20syphilis%20tests%20in%20KwaZulu-Natal.%20J%20Clin%20Lab%20Anal.%202014;28(1):77%E2%80%9381." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Clark M, Grobelna A. Rapid syphilis testing. Can J Health Technol. 2022. 10.51731/cjht.2022.489.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/38620374/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Clark%20M,%20Grobelna%20A.%20Rapid%20syphilis%20testing.%20Can%20J%20Health%20Technol.%202022.%2010.51731/cjht.2022.489." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Gilbert L, Dear N, Esber A, Iroezindu M, Bahemana E, Kibuuka H, Owuoth J, Maswai J, Crowell TA, Polyak CS, Ake JA. Prevalence and risk factors associated with HIV and syphilis co-infection in the African cohort study: a cross-sectional study. BMC Infect Dis. 2021;21:1–7.
</cite> [<a href="https://doi.org/10.1186/s12879-021-06668-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8557019/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34717564/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gilbert%20L,%20Dear%20N,%20Esber%20A,%20Iroezindu%20M,%20Bahemana%20E,%20Kibuuka%20H,%20Owuoth%20J,%20Maswai%20J,%20Crowell%20TA,%20Polyak%20CS,%20Ake%20JA.%20Prevalence%20and%20risk%20factors%20associated%20with%20HIV%20and%20syphilis%20co-infection%20in%20the%20African%20cohort%20study:%20a%20cross-sectional%20study.%20BMC%20Infect%20Dis.%202021;21:1%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>World Health Organization. WHO guideline on syphilis screening and treatment for pregnant women. InWHO guideline on syphilis screening and treatment for pregnant women 2017.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/29757595/" class="usa-link">PubMed</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Sidana R, Mangala HC, Murugesh SB, Ravindra K. Prozone phenomenon in secondary syphilis. Indian J Sex Transm Dis AIDS. 2011;32(1):47–9.
</cite> [<a href="https://doi.org/10.4103/2589-0557.81256" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3139290/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21799578/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sidana%20R,%20Mangala%20HC,%20Murugesh%20SB,%20Ravindra%20K.%20Prozone%20phenomenon%20in%20secondary%20syphilis.%20Indian%20J%20Sex%20Transm%20Dis%20AIDS.%202011;32(1):47%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Peeling RW, Holmes KK, Mabey D, Ronald A. Rapid tests for sexually transmitted infections (STIs): the way forward. Sex Transm Infect. 2006;82(suppl 5):v1–6.
</cite> [<a href="https://doi.org/10.1136/sti.2006.024265" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2563912/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17151023/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Peeling%20RW,%20Holmes%20KK,%20Mabey%20D,%20Ronald%20A.%20Rapid%20tests%20for%20sexually%20transmitted%20infections%20(STIs):%20the%20way%20forward.%20Sex%20Transm%20Infect.%202006;82(suppl%205):v1%E2%80%936." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Mabey DC, Sollis KA, Kelly HA, Benzaken AS, Bitarakwate E, Changalucha J, Chen XS, Yin YP, Garcia PJ, Strasser S, Chintu N. Point-of-care tests to strengthen health systems and save newborn lives: the case of syphilis. PLoS Med. 2012;9(6):e1001233.
</cite> [<a href="https://doi.org/10.1371/journal.pmed.1001233" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3373627/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22719229/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mabey%20DC,%20Sollis%20KA,%20Kelly%20HA,%20Benzaken%20AS,%20Bitarakwate%20E,%20Changalucha%20J,%20Chen%20XS,%20Yin%20YP,%20Garcia%20PJ,%20Strasser%20S,%20Chintu%20N.%20Point-of-care%20tests%20to%20strengthen%20health%20systems%20and%20save%20newborn%20lives:%20the%20case%20of%20syphilis.%20PLoS%20Med.%202012;9(6):e1001233." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Bissessor M. Clinical education: Syphilis. Melbourne Sexual Health Centre. 2021 Mar.</cite>
</li>
<li id="CR10">
<span class="label">10.</span><cite>Centers for Disease Control and Prevention. Sexually Transmitted Infections Treatment Guidelines. 2021: Syphilis During Pregnancy.</cite>
</li>
<li id="CR11">
<span class="label">11.</span><cite>Illinois Department of Public Health. Increasing Early Syphilis Cases in Illinois– Syphilis Staging and Treatment, 2018 Mar.</cite>
</li>
<li id="CR12">
<span class="label">12.</span><cite>World Health Organization. WHO guidelines for the treatment of Treponema pallidum (syphilis). InWHO guidelines for the treatment of Treponema pallidum (syphilis) 2016.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/27631046/" class="usa-link">PubMed</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Pham MD, Wise A, Garcia ML, Van H, Zheng S, Mohamed Y, Han Y, Wei WH, Yin YP, Chen XS, Dimech W. Improving the coverage and accuracy of syphilis testing: the development of a novel rapid, point-of-care test for confirmatory testing of active syphilis infection and its early evaluation in China and South Africa. EClinicalMedicine. 2020;24:100440.
</cite> [<a href="https://doi.org/10.1016/j.eclinm.2020.100440" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7327895/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32637904/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pham%20MD,%20Wise%20A,%20Garcia%20ML,%20Van%20H,%20Zheng%20S,%20Mohamed%20Y,%20Han%20Y,%20Wei%20WH,%20Yin%20YP,%20Chen%20XS,%20Dimech%20W.%20Improving%20the%20coverage%20and%20accuracy%20of%20syphilis%20testing:%20the%20development%20of%20a%20novel%20rapid,%20point-of-care%20test%20for%20confirmatory%20testing%20of%20active%20syphilis%20infection%20and%20its%20early%20evaluation%20in%20China%20and%20South%20Africa.%20EClinicalMedicine.%202020;24:100440." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Papp JR. CDC laboratory recommendations for syphilis testing, united states, 2024. MMWR Recomm Rep. 2024;73:1.
</cite> [<a href="https://doi.org/10.15585/mmwr.rr7301a1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10849099/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38319847/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Papp%20JR.%20CDC%20laboratory%20recommendations%20for%20syphilis%20testing,%20united%20states,%202024.%20MMWR%20Recomm%20Rep.%202024;73:1." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Wu MY, Gong HZ, Hu KR, Zheng HY, Wan X, Li J. Effect of syphilis infection on HIV acquisition: a systematic review and meta-analysis. Sex Transm Infect. 2021;97(7):525–33.
</cite> [<a href="https://doi.org/10.1136/sextrans-2020-054706" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8543214/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33219164/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu%20MY,%20Gong%20HZ,%20Hu%20KR,%20Zheng%20HY,%20Wan%20X,%20Li%20J.%20Effect%20of%20syphilis%20infection%20on%20HIV%20acquisition:%20a%20systematic%20review%20and%20meta-analysis.%20Sex%20Transm%20Infect.%202021;97(7):525%E2%80%9333." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>World Health Organization. Global sexually transmitted infections programme. Dual HIV/syphilis rapid diagnostic tests; 2025.</cite>
</li>
<li id="CR17">
<span class="label">17.</span><cite>Centers for Disease Control (CDC). Guidelines for the prevention and control of congenital syphilis. MMWR Supplements. 1988;37(1):1–3.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/3123914/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Centers%20for%20Disease%20Control%20(CDC).%20Guidelines%20for%20the%20prevention%20and%20control%20of%20congenital%20syphilis.%20MMWR%20Supplements.%201988;37(1):1%E2%80%933." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>All relevant data supporting the study findings are in the manuscript and its supplementary materials. Any additional data can be made available if warranted by the corresponding author.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from AIDS Research and Therapy are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s12981-025-00773-1"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/12981_2025_Article_773.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.1 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12372180/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12372180/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372180%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372180/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12372180/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12372180/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40841981/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12372180/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40841981/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12372180/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12372180/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="BelV7GauDRHSgJ6tIjpJ78oyKoHTJ0FC9QNWqci47E3Ua721TWIPRRHBtb1J3SsV">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
